Abstract
The pharmaceutical industry is undergoing a period of significant transformation. This is driven by advances in technology, increased regulatory scrutiny and evolving market demands. The post Covid-19 pandemic era has affected the pharmaceutical industry to meet these requirements. In this regard, emerging trends include the adoption of digitalization, block chain technology and de-centralized clinical trials. Hence, we review the current trends describing evolving challenges post Covid-19 pandemic.